Fact CheckerSign in

NCT04392504Active, not recruitingPhase 1/2

DART (19-14434) Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients

Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Oct 2024

Status (registry)
Active, not recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
130 (estimated)
First submitted
27 Aug 2024
Start date
27 Sept 2024
Lead sponsor
Oslo University Hospital Hf
Diseases
Lung cancer
NCT number
NCT04392504
EU CT number
2022-502640-12-01
EudraCT number
2019-002537-11

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 130
  • 10 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
North Estonia Medical Centre Foundation
Coordinator of this site? Confirm its status
TallinnEstoniaActive, not recruiting
Oulu University Hospital
Coordinator of this site? Confirm its status
OuluFinlandActive, not recruiting
Tampere University Hospital
Coordinator of this site? Confirm its status
TampereFinlandActive, not recruiting
Turku University Hospital
Coordinator of this site? Confirm its status
TurkuFinlandActive, not recruiting
VIlnius University Hospital
Coordinator of this site? Confirm its status
VilniusLithuaniaActive, not recruiting
Helse Bergen HF
Coordinator of this site? Confirm its status
BergenNorwayActive, not recruiting
Oslo University Hospital HF
Coordinator of this site? Confirm its status
OsloNorwayActive, not recruiting
Stavanger University Hospital
Coordinator of this site? Confirm its status
StavangerNorwayActive, not recruiting
University Hospital Of North Norway HF
Coordinator of this site? Confirm its status
TromsoeNorwayActive, not recruiting
St. Olavs hospital HF
Coordinator of this site? Confirm its status
TrondheimNorwayActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.